期刊
ANTICANCER RESEARCH
卷 40, 期 9, 页码 4843-4856出版社
INT INST ANTICANCER RESEARCH
DOI: 10.21873/anticanres.14487
关键词
Colorectal cancer; fatty acid synthesis; fatty acid oxidation; inhibitors; review
类别
资金
- National Science Centre of Poland [2016/22/E/NZ4/00665]
- Medical University of Gdansk [ST-40]
Aberrant fatty acid (FA) metabolism has long been recognized in colorectal cancer (CRC) cells. Since de novo lipogenesis is required for CRC tumour growth and survival, the inhibition of FA metabolism is a promising potential therapeutic target. Inhibition of the opposite process, beta-oxidation of FAs, has also showed promising results in many CRC models. For patients with CRC, both FA synthesis and beta-oxidation inhibitors are promising potential therapeutic options as monotherapies or as combination therapies with other anticancer agents. In this review, we discuss recent reports concerning inhibitors of FA synthesis and beta-oxidation in various CRC models. The exact mechanisms of action of the selected compounds described in this review remain unknown and require precise evaluation before the development of new successful therapies for CRC is possible.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据